Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A proprietary multi-ingredient dietary supplement that combines **full-spectrum hemp oil** (providing phytocannabinoids), **calamari oil** (source of omega-3 fatty acids, including EPA and DHA), and **broccoli extract** (providing glucoraphanin, a precursor to sulforaphane). This formulation is designed to support pain reduction, healthy inflammatory response, the endocannabinoid system, and endogenous antioxidant defenses. Mechanisms involve modulation of the endocannabinoid system (ECS) via phytocannabinoids and omega-3 fatty acids, which converge to help regulate inflammation and pain signaling pathways. Broccoli extract supports antioxidant defenses through Nrf2/ARE pathway activation, and sulforaphane from glucoraphanin may regulate inflammatory responses[1][3][4]. Developed for use in chronic pain management, the product has demonstrated efficacy in reducing pain intensity, interference with daily activities, and oxidative stress in a randomized controlled trial[1][2]. It is generally marketed as a softgel dietary supplement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hemp Oil Complex.